Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 03, 2015 11:05 AM ET

Biotechnology

Company Overview of Xenon Pharmaceuticals Inc.

Executive Profile

Johnston L. Evans BA

Former Independent Director and Member of Audit Committee, Xenon Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
66$51,832

Background

Mr. Johnston L. Evans, also known as John, BA served as the Managing Director and General Partner of Invesco Private Capital. Mr. Evans is a Veteran Venture Capitalist with more than 3 decades of investment experience. He focuses on consumer retail, financial services, technology and special situation investments. After joining Invesco Private Capital (through a predecessor firm) in 1995, Mr. Evans has led investments in Accessline, Ambit Design Systems, AnyTime Access, ...

Corporate Headquarters

3650 Gilmore Way
Burnaby, British Columbia V5G 4W8

Canada

Phone: 604-484-3300
Fax: 604-484-3450

Board Members Memberships

Former Director
Former Director
Former Director
Director
Director
2005-2013
Former Director, Member of Compensation Committee and Member of Corporate Governance & Nominating Committee
2008-2015
Former Independent Director and Member of Audit Committee

Education

BA 1970
Boston University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Unexercisable Options$5,144
Unexercisable Options Value$64,099
Total Value of Options$64,099
Total Number of Options$5,144

Total Compensation

Total Annual Cash Compensation$23,753
Total Calculated Compensation$51,832
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Xenon Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.